StockNews.AI
BDSX
StockNews.AI
2 hrs

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

1. Biodesix hosts events for lung health advocacy in Colorado this October. 2. Collaboration with APAPP to educate on lung disease and cancer screening. 3. Support for Go2 Summit aims to standardize lung nodule management. 4. Participation in American Lung Association's fundraiser promotes lung health awareness. 5. CEO emphasizes events as precursors to Lung Cancer Awareness Month.

5m saved
Insight
Article

FAQ

Why Bullish?

The announcement positions BDSX as a leader in lung health advocacy, potentially increasing brand visibility and trust, which may positively influence investor sentiment, similar to past successful advocacy initiatives by other health firms which led to price increases.

How important is it?

The article discusses events that advance BDSX's mission and visibility, indicating strong community engagement which usually correlates with stock performance, enhancing likelihood of a short-term positive effect.

Why Short Term?

The events align with immediate awareness campaigns, potentially driving short-term interest and sales growth through increased visibility in the lead-up to Lung Cancer Awareness Month.

Related Companies

APPPGO2LUNG
October 06, 2025 10:13 ET  | Source: Biodesix, Inc. Biodesix partners with three leading Lung Health organizations to bring education and advocacy to healthcare professionals and patients LOUISVILLE, Colo., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announced three Colorado-based events in October for healthcare professionals and community members to collaborate, learn, and advocate for lung health. First Event: October 9th APAPP Know Your Nodules Event at Biodesix Head Office in Louisville, CO The Association of Pulmonary Advanced Practice Providers (APAPP) Leadership and expert Faculty will run a half-day event: Know Your Nodules: Personalize. Prioritize. Prevent. APAPP Leadership will be hosting a clinician-centered lung disease and lung cancer screening / detection learning event at the Biodesix Corporate Headquarters in Louisville, Colorado. The event will also be live streamed. Faculty includes Corinne Young (President & Founder, APAPP), Stephen Deppen, PhD (Associate Professor of Thoracic Surgery and Epidemiology, Vanderbilt Medical Center), Rebecca Priebe (Acute Care Nurse Practitioner, Henry Ford Health), and Tammy Welch (Physician Assistant, Frederick Regional Health System). Second Event: October 9th – 11th Go2 for Lung Cancer Centers of Excellence Summit in Denver, CO The Go2 Association is hosting their annual Lung Cancer Centers of Excellence Summit in downtown Denver. This highly specialized educational event includes a full-day Lung Cancer Nurse Navigator module. Biodesix is a proud supporter of Go2 as they are driving to standardize best practices in lung nodule management at a national level. More details here. Third Event: October 12th American Lung Association in Colorado “Run the Rocks” at Red Rocks Amphitheater in Morrison, CO The American Lung Association in Colorado holds their annual Run the Rocks fundraiser and community awareness event at the world-renowned Red Rocks Amphitheater. The purpose of this event is to raise funds for education, research, and advocacy to save lives by improving lung health and preventing lung disease. More details here. “It is a privilege and honor to collaborate with these three partners here in our home state of Colorado. They each uniquely assist in our journey to achieve the Biodesix mission to conquer lung diseases through personalized diagnostics,” said Scott Hutton, CEO at Biodesix. "I’d also like to note that these October events are well-timed as forerunners for November, which is Lung Cancer Awareness Month -- an important time of year for Biodesix advocacy and awareness efforts.” About Biodesix: Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com. Biodesix Contacts:Media:Natalie St. Denis, Director Corporate Communications, Biodesixnatalie.stdenis@biodesix.com(720) 925-9285 Investors:Chris Brinzey, Partner, ICRchris.brinzey@icrhealthcare.com(339) 970-2843

Related News